Humans14,848 participantsCross-sectional study

Lipoprotein(a) levels and estimated QRISK3 cardiovascular risk in the Randox Health 2025 cohort: a cross-sectional analysis of 14,848 individuals

Frontiers in Cardiovascular Medicine

The paper

Randox (United Kingdom)

Frontiers in Cardiovascular Medicine · 16 Sep 2026

doi.org/10.3389/fcvm.2026.1949855PubMed 42819403